Glucose Uptake-Glo™ Assay

Part Numbers: J1341, J1342, J1343

J1341_Glucose-Uptake-Glo-Assay-5ml-3
customize-this-small

細胞内のグルコース取込み量を測定するためのNon-RI のシンプルな発光アッセイ

  • ホモジニアスなプロトコール
  • 高感度で広範な測定レンジ
  • 信頼性、再現性の高い実験データ

Size

選択製品のカタログ番号: J1341

Please Enquire
This product is discontinued
Request a Sample
Not available in all countries
This product is available under our Early Access program - Learn More
This product is available under our Catalog (FT) program - Learn More
Glucose Uptake-Glo™ Assay
5ml
Your price:
Change Configuration

Measuring Glucose Uptake

Glucose metabolism is a key process in many organisms. A lack of insulin-stimulated glucose uptake is associated with type 2 diabetes, while high glucose uptake is a sign of the high glycolytic rates associated with cancer. Measuring glucose uptake can determine the effects of various treatments for diabetes and cancer.

The gold standard method of assaying glucose uptake relies on detection of radio-labeled glucose analogs. Alternative colorimetric and fluorometric glucose uptake assays often lack the sensitivity and robustness needed to reliably measure glucose uptake in cells.

シンプルでNon-RI のグルコース取込みアッセイ

Glucose Uptake-Glo™ Assay は細胞でのグルコース取込みを発光法により測定するプレートベースのホモジニアスアッセイで、2-deoxyglucose-6-phosphate (2DG6P) の検出がベースになっています。


"Promega products are reliable and can be purchased without any hesitation. My experiment went very well as expected and we have more plans to conduct uptake experiments using the Glucose Uptake-Glo™ Assay."


Dr. Vivek Pandey, Postdoctoral Scholar, University of Kentucky.
13497MD-W-a
13497MD-W-b

Glucose Uptake-Glo と従来のRI 法との比較

2-デオキシグルコース (2DG) を細胞に添加するとグルコースと同様に細胞膜を透過し、迅速にリン酸化され、2-deoxyglucose-6-phosphate (2DG6P) を生成します。Stop Buffer を加えると2DGの輸送が停止し、細胞を溶解し、細胞内に残存するNADPHを破壊してタンパク質を不活性化します。Neutralization Buffer を添加すると 2DG6P Detection Reagent 添加前の溶液が中和されます。試薬に含まれる glucose-6-phosphate dehydrogenase (G6PDH) は 2DG6P を酸化して6-phosphodeoxygluconate (6PDG) を生じ、NADP+を還元してNADPHにします。レダクターゼはNADPHを用いてルシフェリン前駆体から発光酵素ルシフェラーゼの基質ルシフェリンに変換します。

14130MA-W-a
14130MA-W-b

がんおよび脂肪細胞株における代謝変化の測定

MCF7 がん細胞

がんモデルでは細胞が酸素不足になると、この低酸素条件により細胞内代謝が酸化的リン酸化から解糖系にシフトします。この結果としてグルコースの取込みが増加します。

13730MC-W-a
13730MC-W-b
13730MC-W-c

MCF7 cells grown under hypoxia (1% oxygen) show an increase in Glucose Uptake-Glo™, indicating an increased glycolytic rate. The same cells demonstrate no significant change in viability using the RealTime-Glo™ and CellTiter-Fluor™ Assays.


脂肪細胞

脂肪細胞モデルを用いて、3T3L1-MBX 脂肪細胞のグルコース取込み量の変化が細胞健全性に対して顕著な影響を与えなかったことを示しました。Glucose Uptake-Glo™ Assay と RealTime-Glo™ Assay のマルチアッセイにより細胞健全性に対する影響とグルコース取込み変化をすぐに分離して測定することができた。

13506MB-W-a

Results of the Glucose Uptake-Glo™ Assay when adipocyte cells are treated under various conditions, where "None" indicates the basal level of glucose uptake. Insulin induces translocation of glucose transporters to the cell surface, and thus increases glucose uptake above basal levels. Cytochalasin B is a glucose transporter inhibitor which decreases glucose uptake. LY294002, a phosphatidylinositol 3-kinase (PI3K) inhibitor, is an essential insulin signaling enzyme which decreases glucose uptake relative to insulin alone.

13506MB-W-b

Results of the RealTime-Glo™ Assay when adipocyte cells are treated under various conditions, where "None" indicates the basal level of glucose uptake. Although there are dramatic changes in glucose uptake, as seen in the accompanying panel, there are minimal changes in viability as measured by the RealTime-Glo™ Assay.

FAQs

Have questions about this assay? Check our frequently asked questions to find answers.

See FAQs

製品仕様

You are viewing: J1341 Change Configuration

選択製品の構成品内容

Item Part # Size

Luciferase Reagent

J151A 1 × 5ml

Stop Buffer

J152A 1 × 15ml

Neutralization Buffer

J153A 1 × 15ml

NADP+

J154A 1 × 50μl

G6PDH

J155A 1 × 125μl

2DG

J156A 1 × 250μl

2DG6P Standard

J157A 1 × 50μl

Reductase

G884C 1 × 25μl

Reductase Substrate

G885A 1 × 55μl

分析証明書

Search by lot number

使用制限

For Research Use Only. Not for Use in Diagnostic Procedures.

保存条件

AA

パテントおよび免責条項

U.S. Pat. Nos. 9,273,343 and 9,951,372, European Pat. No. 2751089, Japanese Pat. No. 6067019 and other patents pending.

製品仕様

You are viewing: J1342 Change Configuration

選択製品の構成品内容

Item Part # Size Concentration

Luciferase Reagent

J151B 1 × 10ml

Stop Buffer

J152A 1 × 15ml

Neutralization Buffer

J153A 1 × 15ml

NADP+

J154B 1 × 100μl

G6PDH

J155B 1 × 250μl

2DG

J156A 1 × 250μl

2DG6P Standard

J157A 1 × 50μl

Reductase

G884A 1 × 55μl 6mg/ml

Reductase Substrate

G885A 1 × 55μl

分析証明書

Search by lot number

使用制限

For Research Use Only. Not for Use in Diagnostic Procedures.

保存条件

AA

パテントおよび免責条項

U.S. Pat. Nos. 9,273,343 and 9,951,372, European Pat. No. 2751089, Japanese Pat. No. 6067019 and other patents pending.

製品仕様

You are viewing: J1343 Change Configuration

選択製品の構成品内容

Item Part # Size Concentration

Luciferase Reagent

J151C 1 × 50ml

Stop Buffer

J152A 1 × 15ml

Neutralization Buffer

J153A 1 × 15ml

NADP+

J154C 1 × 500μl

G6PDH

J155C 1 × 1.25ml

2DG

J156A 1 × 250μl

2DG6P Standard

J157A 1 × 50μl

Reductase

G884B 1 × 275μl 6mg/ml

Reductase Substrate

G885A 1 × 55μl

分析証明書

Search by lot number

使用制限

For Research Use Only. Not for Use in Diagnostic Procedures.

保存条件

AA

パテントおよび免責条項

U.S. Pat. Nos. 9,273,343 and 9,951,372, European Pat. No. 2751089, Japanese Pat. No. 6067019 and other patents pending.

Let's find the product that meets your needs.

Talk to a Scientist

scientist-uk-stephen

Stephen

UK